Focus Stocks
Is GlaxoSmithKline Closing in to Support?
- Details
- Published on Thursday, 30 August 2012 06:44
- Written by TradersHuddle Wire
New York, August 30th (TradersHuddle.com) - Shares of GlaxoSmithKline plc (NYSE:GSK) finished near calculated support at $43.77.
The U.K. based pharmaceutical and health related consumer products maker closed at $45.71 leaving shares at a level that will spark interest by traders wanting to start or add to a position in the stock.
GlaxoSmithKline's stock range is defined by its calculated support defined at $43.77 and by the resistance level at $47.40.
The area where we expect for buyers to materialize is defined as calculated support. A stock trading near its support level might see a lift, if it provides the necessary support for traders to place their buy orders. However, if this area is breached, it will signal participants that the stock failed to entice buyers to step in and support the stock, which in turn will spur additional downward momentum.
Traders wanting to establish a position should pay close attention to GlaxoSmithKline's price action, and establish it as close to support as possible, but only after buying materializes. Traders should understand that the resistance point at $47.40 might limit their upside, however, if the stock breaks resistance, it could be a good point to step in and add to the position.Related Articles
- GlaxoSmithKline Is Near a Key Resistance Area
- BREO™ ELLIPTA™ gains US approval for the treatment of COPD
- Trading Idea: - Is GlaxoSmithKline close to Resistance?
- GlaxoSmithKline Is Moving Above Resistance
- GlaxoSmithKline Is Near a Key Resistance Area
- GlaxoSmithKline Is Moving Above Resistance
- GlaxoSmithKline CFO Interviewed on Q1 2013 Financial Results
- GlaxoSmithKline Is Near a Key Resistance Area
- Above Resistance: GlaxoSmithKline
- FDA Advisory Committee recommends approval of BREO™ ELLIPTA™ for the treatment of COPD
Related Partner Headlines
- GlaxoSmithKline Stock To Go Ex-dividend Tomorrow (GSK) - TheStreet.com
- GlaxoSmithKline PLC (GSK): Today's Featured Drugs Laggard - TheStreet.com
- Buzz on Sarepta's Eteplirsen From London Duchenne Meeting - TheStreet.com
- GlaxoSmithKline PLC (GSK): Today's Featured Health Care Winner - TheStreet.com
- GlaxoSmithKline PLC (GSK): Today's Featured Health Care Winner - TheStreet.com
- United Therapeutics Could Lose The Battle For PAH Therapies - TheStreet.com
- A Prescription for Election Fever - TheStreet.com
- GlaxoSmithKline PLC (GSK): Today's Featured Drugs Laggard - TheStreet.com
- How to Hedge Profits in Sarepta Therapeutics - TheStreet.com
- Lazard Analyst Note on Sarepta Therapeutics Is Generating Buzz - TheStreet.com
TradersHuddle Search
|
Stock Search: |
|
Site Search: Loading
|
Latest Partner Headlines
-
Dow Today: Verizon Communications (VZ) Higher - TheStreet.com -
Separating the Bargains From the Busts - TheStreet.com -
Cramer Quick Take: The 60-Inch TV Will Be Key This Holiday - TheStreet.com -
Cramer Quick Take: Cisco Wins If Fiscal Cliff Is Resolved - TheStreet.com -
Gap Up and Sit - TheStreet.com -
Apple, Intel, MicroStrategy: Tech Winners & Losers - TheStreet.com -
Windows 8 PC Sales Disappointing: Report - TheStreet.com -
Cramer Quick Take: Buy Home Depot and Lowe's - TheStreet.com
Stock Market
Dow Jones
Company ID [INDEXDJX:.DJI] Last trade:15,354.40 Trade time:4:40PM EDT Value change:▲121.18 (0.80%)S&P 500
Company ID [INDEXSP:.INX] Last trade:1,667.47 Trade time:4:39PM EDT Value change:▲17.00 (1.03%)NASDAQ
Company ID [INDEXNASDAQ:.IXIC] Last trade:3,498.97 Trade time:5:15PM EDT Value change:▲33.73 (0.97%)In The Wires
-
Professionally Designed Wedding Dresses Now Online At Tidebuy.com -
DressFirst.com Is Providing Big Discounts On All Its Prom Dresses -
Great Discounts On Evening Dresses Announced by AmorModa.com -
Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses In Excess Of $100,000 Investing In Vitamin Shoppe, Inc. To Contact The Firm -
Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses In Excess Of $100,000 Investing In Ventrus Biosciences, Inc. To Contact The Firm -
Bruno Mars Ticket Prices Slashed at TicketProcess.com - Discounted Tickets Are Still Available With The Trusted Ticket Exchange Giant -
Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses In Excess Of $100,000 Investing In Delcath Systems, Inc. To Contact The Firm -
The Rolling Stones Tour Tickets 2013 On Sale At TicketsTeam.com








